Scarica l'app Stockscreener
3.74
0.54%
0.02
Dopo l'orario di chiusura:
3.82
0.08
+2.14%
Precedente Chiudi:
$3.72
Aprire:
$3.72
Volume 24 ore:
2.29M
Relative Volume:
1.42
Capitalizzazione di mercato:
$517.18M
Reddito:
-
Utile/perdita netta:
$-45.44M
Rapporto P/E:
-10.69
EPS:
-0.35
Flusso di cassa netto:
$-42.28M
1 W Prestazione:
-5.79%
1M Prestazione:
+6.86%
6M Prestazione:
+101.08%
1 anno Prestazione:
+128.05%
Intervallo 1D:
$3.63
$3.84
Intervallo di 1 settimana:
$3.63
$4.265
Portata 52W:
$1.27
$4.86
Compass Therapeutics Inc Stock (CMPX) Company Profile
Nome
Compass Therapeutics Inc
Settore
Industria
Telefono
617-500-8099
Indirizzo
80 GUEST STREET, BOSTON
Confronta CMPX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CMPX
Compass Therapeutics Inc
|
3.74 | 638.25M | 0 | -45.44M | -42.28M | -0.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-01 | Ripresa | Raymond James | Outperform |
| 2025-04-02 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-24 | Iniziato | Guggenheim | Buy |
| 2025-02-19 | Iniziato | Piper Sandler | Overweight |
| 2024-12-23 | Iniziato | D. Boral Capital | Buy |
| 2024-11-15 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-09-16 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2023-01-31 | Iniziato | Jefferies | Buy |
| 2023-01-27 | Iniziato | Stifel | Buy |
| 2022-05-23 | Ripresa | H.C. Wainwright | Buy |
| 2022-03-15 | Iniziato | Ladenburg Thalmann | Buy |
| 2022-01-19 | Iniziato | B. Riley Securities | Buy |
| 2021-12-22 | Iniziato | Raymond James | Outperform |
| 2021-12-20 | Iniziato | SVB Leerink | Outperform |
| 2021-12-15 | Iniziato | Wedbush | Outperform |
Mostra tutto
Compass Therapeutics Inc Borsa (CMPX) Ultime notizie
How Compass Therapeutics Inc. stock performs in stagflationTrade Risk Assessment & Long Hold Capital Preservation Plans - newser.com
Will Compass Therapeutics Inc. stock outperform growth indexesTake Profit & Verified Entry Point Signals - newser.com
How to interpret RSI for Compass Therapeutics Inc. stockJuly 2025 Selloffs & Low Volatility Stock Recommendations - newser.com
Will Compass Therapeutics Inc. stock split attract more investorsJuly 2025 Price Swings & Free Expert Approved Momentum Trade Ideas - newser.com
Is Compass Therapeutics Inc. stock recession proofJuly 2025 Reactions & Daily Profit Focused Stock Screening - newser.com
How Compass Therapeutics Inc. stock trades before earningsJuly 2025 Breakouts & Reliable Trade Execution Plans - newser.com
Why Compass Therapeutics Inc. stock is seen as undervaluedPortfolio Value Summary & Weekly Stock Breakout Alerts - newser.com
Piper Sandler Remains Bullish on Compass Therapeutics (CMPX) - Insider Monkey
How to track smart money flows in Compass Therapeutics Inc.Quarterly Investment Review & Weekly High Potential Alerts - newser.com
Compass Therapeutics’ Phase 1 Study of CTX-8371: A Potential Game-Changer in Cancer Treatment - TipRanks
Compass Therapeutics (NASDAQ:CMPX) Earns "Sell (D-)" Rating from Weiss Ratings - MarketBeat
Compass Therapeutics Inc Azioni (CMPX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):